Skip to content

Clinical trials

Phase 3 Primary Myelofibrosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 3 Country / region: Italy Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20111
20131
20141
20161
20171
20191
20203
20216
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting6
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Celgene3
AbbVie2
Incyte Corporation2
Sierra Oncology LLC - a GSK company2
CTI BioPharma1
European Organisation for Research and Treatment of Cancer - EORTC1
Geron Corporation1
Kartos Therapeutics, Inc.1
Karyopharm Therapeutics Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis23
Myeloproliferative Disorders8
Anemia6
Bone Marrow Diseases3
Hematologic Diseases3
Neoplasms3
Polycythemia Vera3
Thrombocythemia, Essential3
Splenomegaly2
Anemia, Diamond-Blackfan1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.